Job description
Roche fosters diversity, equity and inclusion, representing the communities we serve. When dealing with healthcare on a global scale, diversity is an essential ingredient to success. We believe that inclusion is key to understanding people’s varied healthcare needs. Together, we embrace individuality and share a passion for exceptional care. Join Roche, where every voice matters. The PositionCo-ordinate and execute month end, quarter end and year end closing activities to ensure timely and accurate closure of accounts in compliance with work instructions and month end close checklistPreparation of accounting journals and ensure it is prepared accurately and posted timely.Prepare monthly balance sheet reconciliation, highlight and rectify any anomalies encountered, including clearing of open itemsSubmission of monthly, quarterly and yearly reporting packages accurately and within specified timescale (eg: FinCo, Sustanability, Insurance, etc)Support internal and external audit matters by ensuring timely submission of required audit schedules and providing financial supporting documents and information to auditors
Responsibilities & skills
Education
Control Financial Reporting (ICFR), group policies and guidelines, local statutory and legal requirements within agreed service timelinesEngage and support the teams in the implementation of continuous improvement project.Proactively identify, recommend and implement solutions in consultation with the management for continuous improvement opportunities in the areas of operation
Experience
Ready to apply?
Sign in and make sure your profile and resume are up to date.
Roche
Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.We are the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies.We have been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers.We offer doctors profound information to guide treatments and to answer more patients’ questions than any other company. And our tests enable hospitals and labs to deliver that information quickly and reliably.We invest around 9 billion Swiss francs in Research and Development every year because innovation is our lifeblood. This is amongst the highest Research and Development spends in the world across all industries.
View company profile